Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of two doses of QVAR versus placebo by breath operated and metered dose inhalers in moderate asthmatic adolescents and adults on a stable regimen of inhaled corticosteroids

Next Previous
Trial Profile

Evaluation of two doses of QVAR versus placebo by breath operated and metered dose inhalers in moderate asthmatic adolescents and adults on a stable regimen of inhaled corticosteroids

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Teva Branded Pharmaceutical Products R&D

Most Recent Events

  • 26 Aug 2011 Lead trial center identified as reported by ClinicalTrials.gov.
  • 18 Sep 2008 Teva pharmaceutical industries added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
  • 01 May 2007 Results have been reported.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top